Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Hemodynamic Stability in Spine Surgery
NCT05644483Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Mar 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Asan Medical Center. Primary endpoints: Number of hypotensive episodes per patient and Number of severe hypotensive episodes per patient. Started Mar 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05644483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644483.